维普中文期刊产品整合服务
69篇 您的检索式:作者名="Parmiani"
    题名 作者 年代 出处 被引量
1Analysis of TCR usage in human tumors:a new tool for assessing tumor-specific immune responses显示文摘Sensi M Parmiani G 1995Immunol Today1995,16,12:1
2Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients显示文摘Di Rienzo V Pagani A Parmiani S 1999Allergy1999,54,10:1
3Tumor Immunology显示文摘Parmiani G Lotze M T 2002Taylor and Francis Group2002,11,6:1
4Heat shock proteins and their use as, anticancer vaccines显示文摘PARMIANI G TESTORI A MAIO M 2004Clin Cancer Res2004,10,81:1
5Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients显示文摘Di Rienzo V Pagani A Parmiani S 1999Allergy1999,54,10:1
6Post-marketing surveillance study on the safety of sublingual immunotherapy in pediatric patients显示文摘Di Rienzo V Pagani A Parmiani S 1999Allergy1999,54,10:1
7TNK cells (NKG2D+CD8+ or CD4+ T lymphocytes) in the control of humantumors显示文摘Maccalli C Scaramuzza S Parmiani G 2009Cancer Immunol Immunother2009,58,5:1
8Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer显示文摘Chiara Castelli Licia Rivoltini Francesca Rini Filiberto Belli Alessandro Testori Michele Maio Vincenzo Mazzaferro Jorgelina Coppa Pramod K. Srivastava Giorgio Parmiani 2004Cancer Immunology Immunotherapy2004,,3:1
9Universal and sternness - related tumor antigens : potential use in cancer immunotherapy 显示文摘Parmiani G Russo V Marrari A 2007Clin Cancer Res2007,13,19:1
10A clinical development paradigm for cancer vaccines and related biologics 显示文摘Hoos A Parmiani G Hege K 2007Immunother2007,30,1:1
11Cancer immunotherapy with peptide-based vaccines:What have we achieved? Where are we going?显示文摘Parmiani G Castelli C Dalerba P 2002J Natl Cancer Inst2002,94,:1
12T cell infiltration and prognosis in HCCpatients显示文摘Parmiani G Anichini A 2006J Hepatol2006,45,2:1
13A listing of human tumor antigens recognized by T cells: March 2004 update 显示文摘Novellino L Castelli C Parmiani G 2005Cancer Immunol Immunother2005,54,:1
14Cytokines in cancer therapy显示文摘 Rivoltini L Andreola G 2000Immunol Lett2000,1574,1:1
15International meeting, lmmunotherapy of cancer: challenges and needs 显示文摘Ferrantini M Capone 1 Marincola FM Parmiani G Belardelli F 2007Cancer hnmunol Immunother2007,56,4:1
16Variation of the skin end-point in patients treated with sublingual specific im munotherapy显示文摘BORDIGNON V PARMIANI S 2003J Investig Allergol Clin Immunol2003,13,:1
17Loco-regional immunotherapy with recombinant interleukin-2 and adherent lymphokine-activated killer cells (A-LAK) in recurrent glioblastoma patients显示文摘Amerigo Boiardi Antonio Silvani Pier Adelchi Ruffini Licia Rivoltini Giorgio Parmiani Giovanni Broggi Andrea Salmaggi 1994Cancer Immunology Immunotherapy1994,,3:1
18Genes involved in melanoma: an overview of ink4a and other loci 显示文摘Castellano M Parmiani G 1999Melanoma Res1999,9,5:1
19International Meeting on Cancer Vaccines : how Can we Enhance Efficacy of Therapeutic Vaccines 显示文摘BELARDELLI F FERRANTINI M PARMIANI G 2004Cancer Res2004,64,18:1
20Cytokine gene transduction in the immunotherapy of cancer显示文摘Parmiani G Colombo MP Melani C 1997Adv Pharmacol1997,40,2:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费